Search research articles
Contact Us
Filters
Showing results (11-20 of 88) with videos related to
Page
of 9
Sort By:
Atherosclerosis
|
February 17, 2009
Endothelin-1 activates ETA receptors on human vascular smooth muscle cells to yield proteoglycans with increased binding to LDL
Mandy L Ballinger, Melanie E Ivey, Narin Osman, et al.
Asia-Pacific Journal of Clinical Oncology
|
March 1, 2016
International survey of awareness of genetic risk in the clinical sarcoma community
Kate A McBride, Timothy E Schlub, Mandy L Ballinger, et al.
European Journal of Human Genetics : EJHG
|
October 4, 2021
My Research Results: a program to facilitate return of clinically actionable genomic research findings
Amanda M Willis, Bronwyn Terrill, Angela Pearce, et al.
Cardiovascular & Hematological Disorders Drug Targets
|
December 17, 2008
p38 MAP kinase mediated proteoglycan synthesis as a target for the prevention of atherosclerosis
Narin Osman, Mandy L Ballinger, Harsha M Dadlani, et al.
Archives of Physiology and Biochemistry
|
July 8, 2009
Growth factor-mediated hyper-elongation of glycosaminoglycan chains on biglycan requires transcription and translation
Sundy N Y Yang, Micah L Burch, Robel Getachew, et al.
Kidney International
|
December 1, 2005
Glycated and carboxy-methylated proteins do not directly activate human vascular smooth muscle cells
Mandy L Ballinger, Merlin C Thomas, Julie Nigro, et al.
Cellular and Molecular Life Sciences : CMLS
|
March 10, 2010
TGF-beta stimulates biglycan synthesis via p38 and ERK phosphorylation of the linker region of Smad2
Micah L Burch, Sundy N Y Yang, Mandy L Ballinger, et al.
Journal of Cardiovascular Pharmacology
|
November 27, 2008
Pyrido-pyrimidine derivative CYC10424 inhibits glycosaminoglycan changes on vascular smooth muscle-derived proteoglycans and reduces lipoprotein binding
Mandy L Ballinger, Narin Osman, Andrew F Wilks, et al.
Journal of Cardiovascular Pharmacology
|
March 22, 2008
Phosphorylated troglitazone activates PPARgamma and inhibits vascular smooth muscle cell proliferation and proteoglycan synthesis
Peter J Little, Mandy L Ballinger, Soniya Survase, et al.
Nature Reviews. Clinical Oncology
|
February 21, 2019
Therapeutic implications of germline genetic findings in cancer
Subotheni Thavaneswaran, Emma Rath, Kathy Tucker, et al.
Page
of 9
Search research articles
Search
Showing results (11-20 of 88) with videos related to
Sort By:
Page
of 9
Atherosclerosis
|
February 17, 2009
Endothelin-1 activates ETA receptors on human vascular smooth muscle cells to yield proteoglycans with increased binding to LDL
Mandy L Ballinger, Melanie E Ivey, Narin Osman, et al.
Asia-Pacific Journal of Clinical Oncology
|
March 1, 2016
International survey of awareness of genetic risk in the clinical sarcoma community
Kate A McBride, Timothy E Schlub, Mandy L Ballinger, et al.
European Journal of Human Genetics : EJHG
|
October 4, 2021
My Research Results: a program to facilitate return of clinically actionable genomic research findings
Amanda M Willis, Bronwyn Terrill, Angela Pearce, et al.
Cardiovascular & Hematological Disorders Drug Targets
|
December 17, 2008
p38 MAP kinase mediated proteoglycan synthesis as a target for the prevention of atherosclerosis
Narin Osman, Mandy L Ballinger, Harsha M Dadlani, et al.
Archives of Physiology and Biochemistry
|
July 8, 2009
Growth factor-mediated hyper-elongation of glycosaminoglycan chains on biglycan requires transcription and translation
Sundy N Y Yang, Micah L Burch, Robel Getachew, et al.
Kidney International
|
December 1, 2005
Glycated and carboxy-methylated proteins do not directly activate human vascular smooth muscle cells
Mandy L Ballinger, Merlin C Thomas, Julie Nigro, et al.
Cellular and Molecular Life Sciences : CMLS
|
March 10, 2010
TGF-beta stimulates biglycan synthesis via p38 and ERK phosphorylation of the linker region of Smad2
Micah L Burch, Sundy N Y Yang, Mandy L Ballinger, et al.
Journal of Cardiovascular Pharmacology
|
November 27, 2008
Pyrido-pyrimidine derivative CYC10424 inhibits glycosaminoglycan changes on vascular smooth muscle-derived proteoglycans and reduces lipoprotein binding
Mandy L Ballinger, Narin Osman, Andrew F Wilks, et al.
Journal of Cardiovascular Pharmacology
|
March 22, 2008
Phosphorylated troglitazone activates PPARgamma and inhibits vascular smooth muscle cell proliferation and proteoglycan synthesis
Peter J Little, Mandy L Ballinger, Soniya Survase, et al.
Nature Reviews. Clinical Oncology
|
February 21, 2019
Therapeutic implications of germline genetic findings in cancer
Subotheni Thavaneswaran, Emma Rath, Kathy Tucker, et al.
Page
of 9